Vascular Inflammation Stratified by Body Size Phenotype

• Vascular Inflammation is a key factor in both the pathogenesis and outcome of atherosclerosis. 18FDG-PET is a promising novel tool for identifying and quantifying vascular inflammation within atherosclerotic plaque
• Recently, unique subsets of obese individuals, such as metabolically obese but normal weight (MONW) and metabolically healthy obese (MHO), have been getting an attention
• Therefore, the purpose of this study is to examine the relationship of vascular inflammation,measured by FDG-PET, with various body sized phenotypes

Inclusion Criteria:

• Healthy patients for visiting routine medical check in our clinic

Exclusion Criteria:

• history of CVD (myocardial infarction, unstable angina, stroke, or cardiovascular revascularization)
• stage 2 hypertension (resting blood pressure, ≥160/100 mmHg)
• history of inflammatory conditions that affect the study results
• taking medications that might affect inflammatory status, including steroid and non-steroidal anti-inflammatory drug within 6 months
• or malignancy or severe renal or hepatic disease